Vizishot 2 Flex
Payments companies reported to CMS as associated with Vizishot 2 Flex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vizishot 2 Flex, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vizishot 2 Flex
These are the largest totals companies reported as associated with Vizishot 2 Flex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alexander Chen | Saint Louis, MO | Pulmonary Disease | $56,619.48 |
| Angela Argento | Baltimore, MD | Pulmonary Disease | $42,425.67 |
| Hans Lee | Baltimore, MD | Pulmonary Disease | $26,345.47 |
| Momen Wahidi | Chicago, IL | Pulmonary Disease | $19,082.97 |
| Shawn Nishi | Galveston, TX | Pulmonary Disease | $16,184.60 |
| Septimiu Murgu | Chicago, IL | Pulmonary Disease | $7,260.00 |
| Sonali Sethi | New York, NY | Pulmonary Disease | $4,620.00 |
| Elliot Ho | Loma Linda, CA | Pulmonary Disease | $3,832.50 |
| Michael Machuzak | Cleveland, OH | Pulmonary Disease | $3,341.25 |
| Ahmid Rachid | Southfield, MI | Pulmonary Disease | $876.83 |
Prescribed Vizishot 2 Flex?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.